New York, April 23 -- An Indian-American physician Dr Geetika Srivastava is leading an initiative of the Food and Drug Administration (FDA) in collaboration with the White House Cancer Moonshot Program which will significantly enhance access to oncology clinical trials in India.
India's population comprises nearly 20 per cent of the global populace, yet only a mere 1.5 per cent of global trials are conducted within its borders. Project Asha arises as a crucial response to this disparity.
The name of the project is 'Project Asha'.
The project stems from the landmark Official State visit of Prime Minister Narendra Modi to the US in June 2023, where he and US President Joe Biden committed to alleviating the cancer burden in India.
The two ...